Year |
Citation |
Score |
2023 |
Watt GP, Thakran S, Sung JS, Jochelson MS, Lobbes MBI, Weinstein SP, Bradbury AR, Buys SS, Morris EA, Apte A, Patel P, Woods M, Liang X, Pike MC, Kontos D, et al. Association of Breast Cancer Odds with Background Parenchymal Enhancement Quantified Using a Fully Automated Method at MRI: The IMAGINE Study. Radiology. 308: e230367. PMID 37750771 DOI: 10.1148/radiol.230367 |
0.362 |
|
2023 |
Phung MT, Lee AW, McLean K, Anton-Culver H, Bandera EV, Carney ME, Chang-Claude J, Cramer DW, Doherty JA, Fortner RT, Goodman MT, Harris HR, Jensen A, Modugno F, Moysich KB, ... ... Pike MC, et al. A framework for assessing interactions for risk stratification models: the example of ovarian cancer. Journal of the National Cancer Institute. PMID 37436712 DOI: 10.1093/jnci/djad137 |
0.358 |
|
2023 |
Fu Z, Brooks MM, Irvin S, Jordan S, Aben KKH, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Brooks-Wilson A, Chang-Claude J, Cook LS, Cramer DW, Cushing-Haugen KL, Doherty JA, ... ... Pike MC, et al. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. Journal of the National Cancer Institute. PMID 36688720 DOI: 10.1093/jnci/djad011 |
0.356 |
|
2022 |
Phung MT, Muthukumar A, Trabert B, Webb PM, Jordan SJ, Terry KL, Cramer DW, Titus LJ, Risch HA, Doherty JA, Harris HR, Goodman MT, Modugno F, Moysich KB, Jensen A, ... ... Pike MC, et al. Effects of risk factors for ovarian cancer in women with and without endometriosis. Fertility and Sterility. PMID 36182623 DOI: 10.1016/j.fertnstert.2022.07.019 |
0.402 |
|
2022 |
Brooks JD, Christensen RAG, Sung JS, Pike MC, Orlow I, Bernstein JL, Morris EA. MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women. Npj Breast Cancer. 8: 97. PMID 36008488 DOI: 10.1038/s41523-022-00458-2 |
0.383 |
|
2022 |
Watt GP, Knight JA, Nguyen TL, Reiner AS, Malone KE, John EM, Lynch CF, Brooks JD, Woods M, Liang X, Bernstein L, Pike MC, Hopper JL, Bernstein JL. Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholds. International Journal of Cancer. PMID 35315524 DOI: 10.1002/ijc.34001 |
0.541 |
|
2022 |
Phung MT, Alimujiang A, Berchuck A, Anton-Cluver H, Schildkraut JM, Bandera EV, Chang-Claude J, Chase A, Doherty JA, Grout B, Goodman MT, Hanley GE, Lee AW, McKinnon Deurloo C, Menon U, ... ... Pike MC, et al. Reproductive factors do not influence survival with ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35064059 DOI: 10.1158/1055-9965.EPI-21-1091 |
0.342 |
|
2021 |
Watt GP, Knight JA, Lin C, Lynch CF, Malone KE, John EM, Bernstein L, Brooks JD, Reiner AS, Liang X, Woods M, Nguyen TL, Hopper JL, Pike MC, Bernstein JL. Mammographic texture features associated with contralateral breast cancer in the WECARE Study. Npj Breast Cancer. 7: 146. PMID 34845211 DOI: 10.1038/s41523-021-00354-1 |
0.552 |
|
2021 |
Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, ... ... Pike MC, et al. High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34789471 DOI: 10.1158/1055-9965.EPI-21-0977 |
0.345 |
|
2021 |
Moskowitz CS, Ronckers CM, Chou JF, Smith SA, Friedman DN, Barnea D, Kok JL, de Vries S, Wolden SL, Henderson TO, van der Pal HJH, Kremer LCM, Neglia JP, Turcotte LM, Howell RM, ... ... Pike MC, et al. Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002244. PMID 34048292 DOI: 10.1200/JCO.20.02244 |
0.398 |
|
2021 |
Phung MT, Lee AW, Wu AH, Berchuck A, Cho KR, Cramer DW, Doherty JA, Goodman MT, Hanley GE, Harris HR, McLean K, Modugno F, Moysich KB, Mukherjee B, Schildkraut JM, ... ... Pike MC, et al. Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33619020 DOI: 10.1158/1055-9965.EPI-20-1355 |
0.421 |
|
2020 |
Watt GP, Sung J, Morris EA, Buys SS, Bradbury AR, Brooks JD, Conant EF, Weinstein SP, Kontos D, Woods M, Colonna SV, Liang X, Stein MA, Pike MC, Bernstein JL. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study. Breast Cancer Research : Bcr. 22: 138. PMID 33287857 DOI: 10.1186/s13058-020-01375-7 |
0.332 |
|
2020 |
Lee AW, Rosenzweig S, Wiensch A, Ramus SJ, Menon U, Gentry-Maharaj A, Ziogas A, Anton-Culver H, Whittemore AS, Sieh W, Rothstein JH, McGuire V, Wentzensen N, Bandera EV, ... ... Pike MC, et al. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. Journal of the National Cancer Institute. PMID 32766851 DOI: 10.1093/Jnci/Djaa099 |
0.476 |
|
2020 |
Brieger KK, Peterson S, Lee AW, Mukherjee B, Bakulski KM, Alimujiang A, Anton-Culver H, Anglesio MS, Bandera EV, Berchuck A, Bowtell DDL, Chenevix-Trench G, Cho KR, Cramer DW, DeFazio A, ... ... Pike MC, et al. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. Gynecologic Oncology. PMID 32641237 DOI: 10.1016/J.Ygyno.2020.06.481 |
0.397 |
|
2020 |
Babic A, Sasamoto N, Rosner BA, Tworoger SS, Jordan SJ, Risch HA, Harris HR, Rossing MA, Doherty JA, Fortner RT, Chang-Claude J, Goodman MT, Thompson PJ, Moysich KB, Ness RB, ... ... Pike M, et al. Association Between Breastfeeding and Ovarian Cancer Risk. Jama Oncology. e200421. PMID 32239218 DOI: 10.1001/Jamaoncol.2020.0421 |
0.483 |
|
2020 |
Lee AW, Wu AH, Wiensch A, Mukherjee B, Terry KL, Harris HR, Carney ME, Jensen A, Cramer DW, Berchuck A, Doherty JA, Modugno F, Goodman MT, Alimujiang A, Rossing MA, ... ... Pike MC, et al. Estrogen plus progestin hormone therapy and ovarian cancer: a complicated relationship explored. Epidemiology (Cambridge, Mass.). PMID 32028322 DOI: 10.1097/Ede.0000000000001175 |
0.445 |
|
2020 |
Garsed D, Pandey A, Fereday S, Alsop K, Wouters M, Saner F, Kennedy C, Pearce C, Pike M, Ramus S, Kobel M, deFazio A, Goode E, Nelson B, Bowtell D. Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-Ia05 |
0.347 |
|
2020 |
Phung MT, Webb PM, Doherty JA, Harris HR, Thompson PJ, Goodman MT, Moysich K, Modugno F, Ness RB, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Titus L, Lee AW, ... Pike MC, et al. Abstract B38: Use of progestin-only injectable contraceptive is associated with reduced risk of ovarian cancer in the Ovarian Cancer Association Consortium Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-B38 |
0.508 |
|
2020 |
Phung MT, Mukherjee B, Lee AW, Webb PM, Risch HA, Doherty JA, Harris HR, Goodman MT, Ness RB, Modugno F, Jensen A, Kjaer SK, Terry KL, Cramer DW, Ziogas A, ... ... Pike MC, et al. Abstract 3498: Ovarian cancer risk factors multiply to create high risk in pre-menopausal women Epidemiology. DOI: 10.1158/1538-7445.Am2020-3498 |
0.471 |
|
2020 |
Fazio Ad, Garsed DW, Pandey A, Fereday S, Alsop K, Wouters MCA, Gibson-Wright B, Saner F, Beach JA, Milne K, Kennedy CJ, Hendley J, Traficante N, Ramus SJ, Köbel M, ... ... Pike MC, et al. The MOCOG study: Learning from extraordinary responders to improve treatment outcomes for women with ovarian cancer Pathology. 52. DOI: 10.1016/J.Pathol.2020.01.126 |
0.36 |
|
2019 |
Alimujiang A, Khoja L, Wiensch A, Pike MC, Webb PM, Chenevix-Trench G, Chase A, Richardson J, Pearce CL. "I am not a statistic" ovarian cancer survivors' views of factors that influenced their long-term survival. Gynecologic Oncology. PMID 31706666 DOI: 10.1016/J.Ygyno.2019.10.007 |
0.407 |
|
2019 |
Nguyen TL, Li S, Dite GS, Aung YK, Evans CF, Trinh HN, Baglietto L, Stone J, Song YM, Sung J, English DR, Jenkins MA, Dugué PA, Milne RL, Southey MC, ... ... Pike MC, et al. Interval Breast Cancer Risk Associations with Breast Density, Family History, and Breast Tissue Ageing. International Journal of Cancer. PMID 31609476 DOI: 10.1002/Ijc.32731 |
0.46 |
|
2019 |
Sung JS, Lebron L, Keating D, D'Alessio D, Comstock CE, Lee CH, Pike MC, Ayhan M, Moskowitz CS, Morris EA, Jochelson MS. Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer. Radiology. 182660. PMID 31453765 DOI: 10.1148/Radiol.2019182660 |
0.48 |
|
2019 |
Schildkraut JM, Peres LC, Bethea TN, Camacho F, Chyn D, Cloyd EK, Bandera EV, Beeghly-Fadiel A, Lipworth L, Joslin CE, Davis FG, Moorman PG, Myers E, Ochs-Balcom HM, Setiawan VW, ... Pike MC, et al. Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women. Cancer Causes & Control : Ccc. PMID 31236792 DOI: 10.1007/S10552-019-01199-7 |
0.437 |
|
2019 |
Lee AW, Peterson S, Wiensch A, Pike MC, Pearce CL. Abstract DP-011: PRE-DIAGNOSIS USE OF MENOPAUSAL HORMONE THERAPY ASSOCIATED WITH BETTER OVARIAN CANCER SURVIVAL Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Dp-011 |
0.424 |
|
2019 |
Sasamoto N, Babic A, Jordan S, Risch H, Harris H, Rossing MA, Doherty J, Goodman M, Thompson P, Kjær SK, Jensen A, Schildkraut J, Titus L, Cramer D, Bandera E, ... ... Pike M, et al. Abstract 640: Breastfeeding pattern and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-640 |
0.471 |
|
2019 |
Alimujiang A, Khoja L, Wiensch A, Pike MC, Webb P, Chase A, Richardson J, Pearce CL. Abstract 3288: Ovarian cancer survivors' views of factors that influenced their exceptional survival: A qualitative study Cancer Research. 79: 3288-3288. DOI: 10.1158/1538-7445.Am2019-3288 |
0.396 |
|
2019 |
Garsed DW, Pandey A, Fereday S, Alsop K, Wouters MC, Saner F, Beach JA, Milne K, Kennedy CJ, Hendley J, Traficante N, Pearce CL, Pike MC, Ramus SJ, Köbel M, et al. Abstract 2722: The genomic landscape of high-grade serous ovarian cancer in long-term survivors Cancer Research. 79: 2722-2722. DOI: 10.1158/1538-7445.Am2019-2722 |
0.351 |
|
2018 |
Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, ... ... Pike MC, et al. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Research. PMID 30559148 DOI: 10.1158/0008-5472.Can-18-2726 |
0.355 |
|
2018 |
Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Salvatore M, Tworoger SS, Whittemore AS, Anton-Culver H, Sieh W, Olson SH, Berchuck A, ... ... Pike MC, et al. A Comprehensive Gene-Environment Interaction Analysis in Ovarian Cancer using Genome-wide Significant Common Variants. International Journal of Cancer. PMID 30499236 DOI: 10.1002/Ijc.32029 |
0.469 |
|
2018 |
Westhoff CL, Pike MC. Hormonal contraception and breast cancer. Contraception. 98: 171-173. PMID 30193687 DOI: 10.1016/j.contraception.2018.05.002 |
0.404 |
|
2018 |
Sung JS, Corben AD, Brooks JD, Edelweiss M, Keating DM, Lin C, Morris EA, Patel P, Robson M, Woods M, Bernstein JL, Pike MC. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI. Breast Cancer Research and Treatment. PMID 30140962 DOI: 10.1007/S10549-018-4916-6 |
0.428 |
|
2018 |
Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, ... ... Pike MC, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473 |
0.368 |
|
2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Pike MC, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.427 |
|
2018 |
Westhoff CL, Pike MC. Hormonal contraception and breast cancer. American Journal of Obstetrics and Gynecology. PMID 29779566 DOI: 10.1016/j.ajog.2018.03.032 |
0.405 |
|
2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Pike MC, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.479 |
|
2018 |
Brooks JD, Sung JS, Pike MC, Orlow I, Stanczyk FZ, Bernstein JL, Morris EA. MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women. International Journal of Cancer. PMID 29524207 DOI: 10.1002/Ijc.31370 |
0.423 |
|
2018 |
Weitzel JN, Press MF, Sand SR, Zhang L, Klifa C, Pike M, Ursin G, Spicer DV, Daniels A, Herzog J, Miao Y, Wuenschell G, Li C, Hickey R. Abstract 3262: Biomarkers of response to deslorelin in women at high risk of breast cancer Prevention and Research. DOI: 10.1158/1538-7445.Am2018-3262 |
0.489 |
|
2017 |
Park KJ, Patel P, Linkov I, Jotwani A, Kauff N, Pike MC. Observations on the Origin of Ovarian Cortical Inclusion Cysts in Women Undergoing Risk-Reducing Salpingo-Oophorectomy. Histopathology. PMID 29197096 DOI: 10.1111/His.13444 |
0.381 |
|
2017 |
Wu AH, Pearce CL, Lee A, Tseng C, Jotwani A, Patel P, Pike MC. Timing of births and oral contraceptive use influences ovarian cancer risk. International Journal of Cancer. PMID 28748634 DOI: 10.1002/Ijc.30910 |
0.424 |
|
2017 |
Moskowitz CS, Chou JF, Sklar CA, Barnea D, Ronckers CM, Friedman DN, Neglia JP, Turcotte L, Howell RM, Henderson TO, Armstrong GT, Leisenring WM, Robison LL, van Leeuwen FE, Pike MC, et al. Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study. British Journal of Cancer. PMID 28632729 DOI: 10.1038/Bjc.2017.169 |
0.497 |
|
2017 |
Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, Chen C, Cook LS, Dal Maso L, De Vivo I, Freudenheim JL, Friedenreich CM, La Vecchia C, McCann SE, Moysich KB, ... ... Pike MC, et al. Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. Obstetrics and Gynecology. PMID 28486362 DOI: 10.1097/Aog.0000000000002057 |
0.493 |
|
2017 |
Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, ... ... Pike MC, et al. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 28350790 DOI: 10.1038/Bjc.2017.68 |
0.418 |
|
2017 |
Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, ... ... Pike MC, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/Bjc.2016.426 |
0.321 |
|
2017 |
Westhoff CL, Pike MC, Cremers S, Eisenberger A, Thomassen S, Rosing J. Endogenous Thrombin Potential Changes during the First Cycle of Oral Contraceptive Use. Contraception. PMID 28088496 DOI: 10.1016/J.Contraception.2017.01.001 |
0.315 |
|
2017 |
Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, ... ... Pike M, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies. International Journal of Cancer. PMID 28063166 DOI: 10.1002/Ijc.30600 |
0.403 |
|
2017 |
Bodelon C, Risch H, Modugno F, Webb P, Pearce CL, Pike M, Wentzensen N. Abstract A27: Timing of pregnancies and oral contraceptive use and risk of ovarian cancer Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-A27 |
0.491 |
|
2017 |
Mullins M, Mukherjee B, Wu AH, Pike M, Pharoah PD, Berchuck A, Pearce CL. Explaining Disparities in Ovarian Cancer Incidence Rates between Women of African and European Ancestry: The Role of Genetic Factors. Cancer Epidemiology, Biomarkers & Prevention. 26: 433-434. DOI: 10.1158/1055-9965.Epi-17-0030 |
0.476 |
|
2016 |
Shu CA, Pike MC, Kauff ND. Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations-Reply. Jama Oncology. PMID 27832251 DOI: 10.1001/Jamaoncol.2016.3900 |
0.346 |
|
2016 |
Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore AS, Anton-Culver H, Bandera EV, Berchuck A, ... ... Pike MC, et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American Journal of Epidemiology. PMID 27698005 DOI: 10.1093/Aje/Kww091 |
0.311 |
|
2016 |
Setiawan VW, Pandol SJ, Porcel J, Wei PC, Wilkens LR, Le Marchand L, Pike MC, Monroe KR. Dietary Factors Reduce Risk of Acute Pancreatitis in a Large Multiethnic Cohort. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 27609706 DOI: 10.1016/J.Cgh.2016.08.038 |
0.316 |
|
2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Pike MC, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.345 |
|
2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... ... Pike MC, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.394 |
|
2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... ... Pike MC, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.389 |
|
2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, ... ... Pike MC, et al. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. International Journal of Cancer. PMID 27420401 DOI: 10.1002/Ijc.30274 |
0.471 |
|
2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Pike MC, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.47 |
|
2016 |
Shu CA, Pike MC, Jotwani AR, Friebel TM, Soslow RA, Levine DA, Nathanson KL, Konner JA, Arnold AG, Bogomolniy F, Dao F, Olvera N, Bancroft EK, Goldfrank DJ, Stadler ZK, et al. Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. Jama Oncology. PMID 27367496 DOI: 10.1001/Jamaoncol.2016.1820 |
0.415 |
|
2016 |
MacInnis RJ, Pike MC, Hopper JL. Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer. The New England Journal of Medicine. 374: 2403-4. PMID 27305206 DOI: 10.1056/Nejmc1602861 |
0.46 |
|
2016 |
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... ... Pike MC, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/Bjc.2016.153 |
0.446 |
|
2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... ... Pike MC, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.Epi-15-1330 |
0.355 |
|
2016 |
Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, ... ... Pike MC, et al. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstetrics and Gynecology. PMID 27054934 DOI: 10.1097/01.Ogx.0000489579.62561.B8 |
0.357 |
|
2016 |
Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton LA, Cunningham JM, deFazio A, Doherty JA, Edwards RP, ... ... Pike MC, et al. Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26976855 DOI: 10.1158/1055-9965.Epi-15-1039 |
0.392 |
|
2016 |
Præstegaard C, Kjaer SK, Nielsen TS, Jensen SM, Webb PM, Nagle CM, Høgdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, ... ... Pike MC, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology. 41: 71-79. PMID 26851750 DOI: 10.1016/J.Canep.2016.01.012 |
0.385 |
|
2016 |
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... ... Pike MC, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 |
0.409 |
|
2016 |
Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Barnes HF, Matullo G, Golka K, Gago-Dominguez M, Taylor J, ... ... Pike MC, et al. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Human Molecular Genetics. PMID 26732427 DOI: 10.1093/Hmg/Ddv492 |
0.576 |
|
2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, ... ... Pike MC, et al. Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer Cancer Research. 76: 797-797. DOI: 10.1158/1538-7445.Am2016-797 |
0.456 |
|
2016 |
Berchuck A, Mullins M, Pharoah PDP, Pike M, Schildkraut JM, Pearce CL. Common single nucleotide polymorphisms associated with ovarian cancer risk contribute to the racial disparity in incidence Gynecologic Oncology. 141: 11. DOI: 10.1016/J.Ygyno.2016.04.057 |
0.466 |
|
2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Pike MC, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.377 |
|
2015 |
Liu Y, Pike MC, Wu N, Lin YG, Mucowski S, Punj V, Tang Y, Yen HY, Stanczyk FZ, Enbom E, Austria T, Widschwendter M, Maxson R, Dubeau L. Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived Scent. Plos One. 10: e0139013. PMID 26488398 DOI: 10.1371/Journal.Pone.0139013 |
0.301 |
|
2015 |
Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, Vivo ID, ... ... Pike MC, et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 107. PMID 26464424 DOI: 10.1093/Jnci/Djv279 |
0.651 |
|
2015 |
Wu AH, Spicer D, Garcia A, Tseng CC, Hovanessian-Larsen L, Sheth P, Martin SE, Hawes D, Russell C, MacDonald H, Tripathy D, Su LM, Ursin G, Pike MC. Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density. Cancer Prevention Research (Philadelphia, Pa.). PMID 26276750 DOI: 10.1158/1940-6207.Capr-15-0125 |
0.417 |
|
2015 |
Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... ... Pike MC, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632 |
0.41 |
|
2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Pike MC, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.314 |
|
2015 |
Ness R, Pearce C, Stram D, Berchuck A, Pike M, Pharoah P. LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS: IGCS-0014 06. Ovarian Cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 25: 50. PMID 25955930 DOI: 10.1097/00009577-201505001-00039 |
0.474 |
|
2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Pike MC, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.388 |
|
2015 |
Wu AH, Pearce CL, Tseng CC, Pike MC. African Americans and Hispanics Remain at Lower Risk of Ovarian Cancer Than Non-Hispanic Whites after Considering Nongenetic Risk Factors and Oophorectomy Rates. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1094-100. PMID 25873577 DOI: 10.1158/1055-9965.Epi-15-0023 |
0.421 |
|
2015 |
Davis SJ, Sheppard KE, Anglesio MS, George J, Traficante N, Fereday S, Intermaggio MP, Menon U, Gentry-Maharaj A, Lubinski J, Gronwald J, Pearce CL, Pike MC, Wu A, Kommoss S, et al. Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition. Molecular Cancer Therapeutics. 14: 1495-503. PMID 25852062 DOI: 10.1158/1535-7163.Mct-15-0039 |
0.35 |
|
2015 |
Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN, Doherty JA, Modugno F, Schildkraut JM, Rossing MA, Huntsman DG, ... ... Pike MC, et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 671-6. PMID 25623732 DOI: 10.1158/1055-9965.Epi-14-1128 |
0.47 |
|
2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Pike MC, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.317 |
|
2015 |
Shu CA, Pike MC, Jotwani AR, Friebel TM, Soslow RA, Levine DA, Robson ME, Konner JA, Blum JL, Neuhausen SL, Garber JE, Daly MB, Isaacs C, Eeles RA, Ganz PA, et al. Uterine cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations (BRCA+): A multicenter, prospective study. Journal of Clinical Oncology. 33: 1504-1504. DOI: 10.1200/Jco.2015.33.15_Suppl.1504 |
0.425 |
|
2015 |
Lee A, Pearce CL, Wu A, Pike M. Abstract 868: The effects of age at term-births on risk of ovarian cancer Cancer Research. 75: 868-868. DOI: 10.1158/1538-7445.Am2015-868 |
0.499 |
|
2014 |
Fu YP, Kohaar I, Moore LE, Lenz P, Figueroa JD, Tang W, Porter-Gill P, Chatterjee N, Scott-Johnson A, Garcia-Closas M, Muchmore B, Baris D, Paquin A, Ylaya K, Schwenn M, ... ... Pike MC, et al. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Research. 74: 5808-18. PMID 25320178 DOI: 10.1158/0008-5472.Can-14-1531 |
0.629 |
|
2014 |
Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L, Ibrahim A, Hautman C, Raj PS, Abnet CC, Adjei AA, ... ... Pike MC, et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Human Molecular Genetics. 23: 6616-33. PMID 25027329 DOI: 10.1093/Hmg/Ddu363 |
0.666 |
|
2014 |
Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, ... ... Pike MC, et al. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunology Research. 2: 332-40. PMID 24764580 DOI: 10.1158/2326-6066.Cir-13-0136 |
0.411 |
|
2014 |
Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, ... ... Pike MC, et al. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1421-7. PMID 24740199 DOI: 10.1158/1055-9965.Epi-13-0962 |
0.376 |
|
2014 |
Figueroa JD, Han SS, Garcia-Closas M, Baris D, Jacobs EJ, Kogevinas M, Schwenn M, Malats N, Johnson A, Purdue MP, Caporaso N, Landi MT, Prokunina-Olsson L, Wang Z, Hutchinson A, ... ... Pike MC, et al. Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis. 35: 1737-44. PMID 24662972 DOI: 10.1093/Carcin/Bgu064 |
0.605 |
|
2014 |
Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, ... ... Pike MC, et al. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. Journal of the National Cancer Institute. 106: djt465. PMID 24552677 DOI: 10.1093/Jnci/Djt465 |
0.469 |
|
2014 |
Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, ... ... Pike MC, et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. Journal of the National Cancer Institute. 106: djt431. PMID 24503200 DOI: 10.1093/Jnci/Djt431 |
0.43 |
|
2014 |
Corral R, Lewinger JP, Van Den Berg D, Joshi AD, Yuan JM, Gago-Dominguez M, Cortessis VK, Pike MC, Conti DV, Thomas DC, Edlund CK, Gao YT, Xiang YB, Zhang W, Su YC, et al. Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai. International Journal of Cancer. Journal International Du Cancer. 135: 335-47. PMID 24382701 DOI: 10.1002/Ijc.28693 |
0.422 |
|
2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Pike MC, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.478 |
|
2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Pike MC, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.437 |
|
2014 |
Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Dinney CP, Malats N, Baris D, ... ... Pike MC, et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Human Molecular Genetics. 23: 1387-98. PMID 24163127 DOI: 10.1093/Hmg/Ddt519 |
0.609 |
|
2014 |
Catsburg CE, Gago-Dominguez M, Yuan JM, Castelao JE, Cortessis VK, Pike MC, Stern MC. Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. International Journal of Cancer. Journal International Du Cancer. 134: 125-35. PMID 23775870 DOI: 10.1002/Ijc.28331 |
0.458 |
|
2014 |
Yang HP, Cook LS, Weiderpass E, Adami H, Anderson KE, Cai H, Cerhan JR, Clendenen T, Felix AS, Friedenreich C, Garcia-Closas M, Goodman MT, Liang X, Lissowska J, Lu L, ... ... Pike MC, et al. Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium Cancer Research. 74: 2167-2167. DOI: 10.1158/1538-7445.Am2014-2167 |
0.511 |
|
2014 |
Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, ... ... Pike MC, et al. Erratum: Anthropometric and hormonal risk factors for male breast cancer: Male breast cancer pooling project results (Journal of the National Cancer Institute (2014) 106:3 (djt465) DOI: 10.1093/jnci/djt465) Journal of the National Cancer Institute. 106. DOI: 10.1093/Jnci/Dju117 |
0.472 |
|
2014 |
Shu CA, Pike M, Jotwani AR, Soslow RA, Levine DA, Konner J, Aghajanian C, Offit K, Barakat RR, Kauff ND. 5Risk of developing uterine corpus cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations Gynecologic Oncology. 134: 440. DOI: 10.1016/J.Ygyno.2014.07.082 |
0.427 |
|
2013 |
Yu SS, Spicer DV, Hawes D, Tseng CC, Yang CS, Pike MC, Wu AH. Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients. Frontiers in Oncology. 3: 298. PMID 24380073 DOI: 10.3389/Fonc.2013.00298 |
0.452 |
|
2013 |
Monroe KR, Stanczyk FZ, Besinque KH, Pike MC. The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women. Nutrition and Cancer. 65: 644-52. PMID 23859031 DOI: 10.1080/01635581.2013.795982 |
0.367 |
|
2013 |
Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, ... ... Pike M, et al. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell. 13: 117-30. PMID 23770079 DOI: 10.1016/J.Stem.2013.05.004 |
0.453 |
|
2013 |
Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, ... ... Pike M, et al. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prevention Research (Philadelphia, Pa.). 6: 811-21. PMID 23761272 DOI: 10.1158/1940-6207.Capr-13-0037 |
0.494 |
|
2013 |
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, Strom BL, et al. Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2607-18. PMID 23733771 DOI: 10.1200/Jco.2012.48.2596 |
0.625 |
|
2013 |
Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ, ... ... Pike MC, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. International Journal of Epidemiology. 42: 579-89. PMID 23569193 DOI: 10.1093/Ije/Dyt042 |
0.483 |
|
2013 |
Tao L, Day BW, Hu B, Xiang YB, Wang R, Stern MC, Gago-Dominguez M, Cortessis VK, Conti DV, Van Den Berg D, Pike MC, Gao YT, Yu MC, Yuan JM. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 937-45. PMID 23539508 DOI: 10.1158/1055-9965.Epi-12-1447 |
0.452 |
|
2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Pike MC, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.455 |
|
2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Pike MC, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.397 |
|
2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Pike MC, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.465 |
|
2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Pike MC, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.373 |
|
2013 |
White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL, Schildkraut JM, Menon U, Kjaer SK, Levine DA, ... ... Pike MC, et al. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 987-92. PMID 23513043 DOI: 10.1158/1055-9965.Epi-13-0028 |
0.441 |
|
2013 |
Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, ... ... Pike MC, et al. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 880-90. PMID 23462924 DOI: 10.1158/1055-9965.Epi-12-1030-T |
0.442 |
|
2013 |
Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Greene MH, Jacobs KB, Kanetsky PA, ... ... Pike MC, et al. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Human Molecular Genetics. 22: 2748-53. PMID 23462292 DOI: 10.1093/Hmg/Ddt109 |
0.336 |
|
2013 |
Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, ... ... Pike MC, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/S10552-013-0174-4 |
0.444 |
|
2013 |
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer. 20: 251-62. PMID 23404857 DOI: 10.1530/Erc-12-0395 |
0.509 |
|
2013 |
Clendenen TV, Zeleniuch-Jacquotte A, Moy L, Pike MC, Rusinek H, Kim S. Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement. Journal of Magnetic Resonance Imaging : Jmri. 38: 474-81. PMID 23292922 DOI: 10.1002/Jmri.24002 |
0.322 |
|
2013 |
Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, ... Pike MC, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 433-9. PMID 23269995 DOI: 10.1200/Jco.2012.43.2013 |
0.602 |
|
2013 |
Clendenen TV, Kim S, Moy L, Wan L, Rusinek H, Stanczyk FZ, Pike MC, Zeleniuch-Jacquotte A. Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magnetic Resonance Imaging. 31: 1-9. PMID 22898693 DOI: 10.1016/J.Mri.2012.06.022 |
0.36 |
|
2013 |
Long KC, Pike MC, Otegbeye E, Arnold AG, Stadler ZK, Robson ME, Barakat RR, Offit K, Chi D, Kauff ND. Impact of bilateral oophorectomy on contralateral breast cancer risk in BRCA negative women from site-specific hereditary breast cancer kindreds. Journal of Clinical Oncology. 31: 1511-1511. DOI: 10.1200/Jco.2013.31.15_Suppl.1511 |
0.501 |
|
2013 |
Dueker DC, Stern MC, Conti DV, Pike MC, Cortessis VK. Abstract 3622: Further observation of increasing strength of the smoking-bladder cancer association: The Los Angeles Bladder Cancer Study. Cancer Research. 73: 3622-3622. DOI: 10.1158/1538-7445.Am2013-3622 |
0.391 |
|
2013 |
Long K, Pike M, Otegbeye E, Arnold A, Stadler Z, Robson M, Barakat R, Offit K, Chi D, Kauff N. Cancer risks in women from BRCA-negative hereditary breast and ovarian cancer families Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.308 |
0.51 |
|
2013 |
Barlin J, Pike M, Otegbeye E, Arnold A, Stadler Z, Robson M, Aghajanian C, Offit K, Barakat R, Kauff N. Does postmenopausal risk-reducing salpingo-oophorectomy reduce the risk of BRCA-associated breast cancer? Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.304 |
0.491 |
|
2012 |
King V, Kaplan J, Pike MC, Liberman L, David Dershaw D, Lee CH, Brooks JD, Morris EA. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. The Breast Journal. 18: 527-34. PMID 23002953 DOI: 10.1111/Tbj.12002 |
0.405 |
|
2012 |
Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, et al. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. American Journal of Epidemiology. 176: 269-78. PMID 22831825 DOI: 10.1093/Aje/Kws129 |
0.595 |
|
2012 |
King V, Goldfarb SB, Brooks JD, Sung JS, Nulsen BF, Jozefara JE, Pike MC, Dickler MN, Morris EA. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology. 264: 670-8. PMID 22771878 DOI: 10.1148/Radiol.12112669 |
0.394 |
|
2012 |
King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. European Radiology. 22: 2641-7. PMID 22752463 DOI: 10.1007/S00330-012-2553-8 |
0.373 |
|
2012 |
Wu AH, Spicer DV, Pike MC. Soy isoflavones for breast cancer risk reduction. Cancer Prevention Research (Philadelphia, Pa.). 5: 984-5; author reply . PMID 22693167 DOI: 10.1158/1940-6207.Capr-12-0102 |
0.416 |
|
2012 |
Begg CB, Pike MC. Comment on "the predictive capacity of personal genome sequencing". Science Translational Medicine. 4: 135le3; author reply. PMID 22623736 DOI: 10.1126/Scitranslmed.3004162 |
0.36 |
|
2012 |
Yen HY, Gabet Y, Liu Y, Martin A, Wu NL, Pike MC, Frenkel B, Maxson R, Dubeau L. Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term consequences on estrogen-responsive organs. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 802-11. PMID 22488153 DOI: 10.1038/Labinvest.2012.58 |
0.356 |
|
2012 |
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, ... ... Pike MC, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. The Lancet. Oncology. 13: 385-94. PMID 22361336 DOI: 10.1016/S1470-2045(11)70404-1 |
0.495 |
|
2012 |
Hovanessian-Larsen L, Taylor D, Hawes D, Spicer DV, Press MF, Wu AH, Pike MC, Pearce CL. Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial. Contraception. 86: 238-43. PMID 22325110 DOI: 10.1016/J.Contraception.2011.12.015 |
0.346 |
|
2012 |
Wu AH, Spicer D, Stanczyk FZ, Tseng CC, Yang CS, Pike MC. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prevention Research (Philadelphia, Pa.). 5: 393-402. PMID 22246619 DOI: 10.1158/1940-6207.Capr-11-0407 |
0.308 |
|
2012 |
Davis-Dao C, Koh CJ, Hardy BE, Chang A, Kim SS, De Filippo R, Hwang A, Pike MC, Carroll JD, Coetzee GA, Vandenberg D, Siegmund K, Cortessis VK. Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. The Journal of Clinical Endocrinology and Metabolism. 97: E393-9. PMID 22188741 DOI: 10.1210/Jc.2011-2439 |
0.362 |
|
2012 |
Chung K, Hovanessian-Larsen LJ, Hawes D, Taylor D, Downey S, Spicer DV, Stanczyk FZ, Patel S, Anderson AR, Pike MC, Wu AH, Pearce CL. Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation. Breast Cancer Research and Treatment. 132: 653-60. PMID 22083231 DOI: 10.1007/S10549-011-1870-Y |
0.367 |
|
2012 |
Jiang X, Castelao JE, Yuan JM, Stern MC, Conti DV, Cortessis VK, Pike MC, Gago-Dominguez M. Cigarette smoking and subtypes of bladder cancer. International Journal of Cancer. Journal International Du Cancer. 130: 896-901. PMID 21412765 DOI: 10.1002/Ijc.26068 |
0.422 |
|
2012 |
Liu L, Zhang J, Wu AH, Pike MC, Deapen D. Invasive breast cancer incidence trends by detailed race/ethnicity and age. International Journal of Cancer. Journal International Du Cancer. 130: 395-404. PMID 21351091 DOI: 10.1002/Ijc.26004 |
0.492 |
|
2012 |
Catsburg CE, Corral R, Lewinger JP, Joshi AD, Gago-Dominguez M, Yuan J, Cortessis VK, Pike MC, Stern MC. Abstract A97: Dietary nitrosamines, genetic variation in DNA repair and metabolism genes, and bladder cancer risk in the Los Angeles Bladder Cancer Study Cancer Prevention Research. 5: A97-A97. DOI: 10.1158/1940-6207.Prev-12-A97 |
0.414 |
|
2012 |
Monroe KR, Stanczyk FZ, Besinque K, Pike MC. Abstract 639: The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women Cancer Research. 72: 639-639. DOI: 10.1158/1538-7445.Am2012-639 |
0.365 |
|
2012 |
Sand SR, Klifa C, Press MF, Pike M, Ursin G, Spicer D, Vora L, Daniels A, Blazer KR, Herzog J, Villalobos I, Weitzel JN. Abstract 3557: Reduced ovarian hormones & reduced mammographic & MRI determined breast density inBRCAcarriers following a hormonal chemo-prevention regimen of gonadotropin releasing hormone agonist (GnRHA) & low-dose add-back estrogen & testosterone: Cancer Research. 72: 3557-3557. DOI: 10.1158/1538-7445.Am2012-3557 |
0.448 |
|
2012 |
Liu Y, Yen H, Gabet Y, Wu N, Pike MC, Frenkel B, Maxson R, Dubeau L. Abstract 3279: Potential beneficial effects of the BRCA1 mutation carrier state on bone strength Cancer Research. 72: 3279-3279. DOI: 10.1158/1538-7445.Am2012-3279 |
0.348 |
|
2012 |
Setiawan VW, Yang HP, Pike MC, McCann S, Yu H, Xiang Y, Wolk A, Wentzensen N, Weiss NS, Webb PM, Brandt PAvd, Vijver Kvd, Thompson PJ, Strom BL, Spurdle AB, et al. Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2 Epidemiology. 72: 1029-1029. DOI: 10.1158/1538-7445.Am2012-1029 |
0.61 |
|
2011 |
Lurie G, Wilkens LR, Thompson PJ, Shvetsov YB, Matsuno RK, Carney ME, Palmieri RT, Wu AH, Pike MC, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Whittemore AS, et al. Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. Plos One. 6: e20703. PMID 21673961 DOI: 10.1371/Journal.Pone.0020703 |
0.469 |
|
2011 |
Davis-Dao CA, Siegmund KD, Vandenberg DJ, Skinner EC, Coetzee GA, Thomas DC, Pike MC, Cortessis VK. Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types. Carcinogenesis. 32: 1238-43. PMID 21642359 DOI: 10.1093/Carcin/Bgr104 |
0.399 |
|
2011 |
Wu AH, Yu MC, Stanczyk FZ, Tseng CC, Pike MC. Anthropometric, dietary, and hormonal correlates of serum adiponectin in Asian American women. Nutrition and Cancer. 63: 549-57. PMID 21547847 DOI: 10.1080/01635581.2011.551986 |
0.42 |
|
2011 |
Davis-Dao CA, Henderson KD, Sullivan-Halley J, Ma H, West D, Xiang YB, Gago-Dominguez M, Stern MC, Castelao JE, Conti DV, Pike MC, Bernstein L, Cortessis VK. Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1156-70. PMID 21493870 DOI: 10.1158/1055-9965.Epi-11-0017 |
0.737 |
|
2011 |
King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology. 260: 50-60. PMID 21493794 DOI: 10.1148/Radiol.11102156 |
0.448 |
|
2011 |
Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, ... ... Pike MC, et al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human Molecular Genetics. 20: 2263-72. PMID 21422097 DOI: 10.1093/Hmg/Ddr087 |
0.503 |
|
2011 |
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, et al. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1028-31. PMID 21415361 DOI: 10.1158/1055-9965.Epi-11-0053 |
0.434 |
|
2011 |
Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... ... Pike MC, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405 |
0.479 |
|
2011 |
Gago-Dominguez M, Jiang X, Conti DV, Castelao JE, Stern MC, Cortessis VK, Pike MC, Xiang YB, Gao YT, Yuan JM, Van Den Berg DJ. Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis. 32: 197-202. PMID 21081471 DOI: 10.1093/Carcin/Bgq233 |
0.419 |
|
2011 |
Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, et al. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 128: 2063-74. PMID 20635389 DOI: 10.1002/Ijc.25554 |
0.437 |
|
2011 |
Divan HA, Berg DVD, Cortessis VK, Joshi AD, Gago-Dominguez M, Stern MC, Conti DV, Pike MC, Gao Y, Xiang Y, Yuan J. Abstract A62: Tobacco exposure, risk for bladder cancer, and modification by NAT2 in different ethnic populations Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A62 |
0.455 |
|
2011 |
Corral R, Xiang Y, Yuan J, Stern MC, Lewinger JP, Berg DVD, Joshi AD, Gago-Dominguez M, Cortessis VK, Conti DV, Pike M, Gao Y. Abstract A1: Comprehensive analyses of DNA repair pathways, smoking, and bladder cancer risk in Los Angeles and Shanghai Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A1 |
0.379 |
|
2011 |
Tao L, Day BW, Hu B, Xiang Y, Wang R, Stern MC, Gago-Dominguez M, Cortessis VK, Conti DV, Berg DVD, Pike MC, Gao Y, Yu MC, Yuan J. Abstract 4647: 4-Aminobiphenyl hemoglobin adducts in relation to risk of bladder cancer among lifelong nonsmokers Epidemiology. 71: 4647-4647. DOI: 10.1158/1538-7445.Am2011-4647 |
0.457 |
|
2011 |
Setiawan VW, Karageorgi S, Deming S, Anderson K, Bernstein L, Brinton L, Cai H, Cerhan JR, Chen C, Cozen W, Doherty JA, Freudenheim JL, Goodman MT, Horn-Ross P, Lissowska J, ... ... Pike MC, et al. Abstract 1900: Age at last birth and endometrial cancer risk: Pooled analysis in the Epidemiology of Endometrial Cancer Consortium Cancer Research. 71: 1900-1900. DOI: 10.1158/1538-7445.Am2011-1900 |
0.601 |
|
2011 |
Goldfarb S, King V, Sung J, Pike M, Nulsen B, Jozefara J, Hudis C, Morris E, Dickler M. P2-08-01: Impact of Aromatase Inhibitors on Background Parenchymal Enhancement and Amount of Fibroglandular Tissue on Breast MRI. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-08-01 |
0.404 |
|
2010 |
Cortessis VK, Yuan JM, Van Den Berg D, Jiang X, Gago-Dominguez M, Stern MC, Castelao JE, Xiang YB, Gao YT, Pike MC, Conti DV. Risk of urinary bladder cancer is associated with 8q24 variant rs9642880[T] in multiple racial/ethnic groups: results from the Los Angeles-Shanghai case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 3150-6. PMID 21051319 DOI: 10.1158/1055-9965.Epi-10-0763 |
0.418 |
|
2010 |
Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, ... ... Pike MC, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nature Genetics. 42: 978-84. PMID 20972438 DOI: 10.1038/Ng.687 |
0.34 |
|
2010 |
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... ... Pike MC, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668 |
0.417 |
|
2010 |
Jiang X, Castelao JE, Yuan JM, Groshen S, Stern MC, Conti DV, Cortessis VK, Coetzee GA, Pike MC, Gago-Dominguez M. Hypertension, diuretics and antihypertensives in relation to bladder cancer. Carcinogenesis. 31: 1964-71. PMID 20732908 DOI: 10.1093/Carcin/Bgq173 |
0.454 |
|
2010 |
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, ... ... Pike MC, et al. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". Plos Genetics. 6: e1001016. PMID 20628624 DOI: 10.1371/Journal.Pgen.1001016 |
0.448 |
|
2010 |
Edwards QT, Li A, Pike MC, Kolonel L, Henderson BE, McKean-Cowdin R. Patterns of regular use of mammography--body weight and ethnicity: the Multiethnic Cohort. Journal of the American Academy of Nurse Practitioners. 22: 162-9. PMID 20236401 DOI: 10.1111/J.1745-7599.2009.00488.X |
0.354 |
|
2010 |
Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, ... ... Pike MC, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 600-4. PMID 20142253 DOI: 10.1158/1055-9965.Epi-09-0861 |
0.481 |
|
2010 |
Razavi P, Pike MC, Horn-Ross PL, Templeman C, Bernstein L, Ursin G. Long-term postmenopausal hormone therapy and endometrial cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 475-83. PMID 20086105 DOI: 10.1158/1055-9965.Epi-09-0712 |
0.573 |
|
2010 |
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 245-50. PMID 20056644 DOI: 10.1158/1055-9965.Epi-09-0729 |
0.461 |
|
2010 |
Hong H, Yen HY, Brockmeyer A, Liu Y, Chodankar R, Pike MC, Stanczyk FZ, Maxson R, Dubeau L. Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Research. 70: 221-8. PMID 20028858 DOI: 10.1158/0008-5472.Can-09-3232 |
0.382 |
|
2010 |
Brown LM, Gridley G, Wu AH, Falk RT, Hauptmann M, Kolonel LN, West DW, Nomura AM, Pike MC, Hoover RN, Ziegler RG. Low level alcohol intake, cigarette smoking and risk of breast cancer in Asian-American women. Breast Cancer Research and Treatment. 120: 203-10. PMID 19597702 DOI: 10.1007/S10549-009-0464-4 |
0.474 |
|
2010 |
Reiner AS, Begg CB, Bernstein L, Haile RW, Knight JA, Lynch CF, John EM, Capanu M, Pike MC, Bernstein JL. Abstract B127: Family history of breast cancer and risk of contralateral breast cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B127 |
0.626 |
|
2010 |
Jiang X, Castelao JE, Yuan J, Groshen S, Stern MC, Conti DV, Cortessis VK, Coetzee GA, Pike MC, Gago-Dominguez M. Abstract 860: Hypertension, diuretics, and antihypertensives in relation to bladder cancer Cancer Research. 70: 860-860. DOI: 10.1158/1538-7445.Am10-860 |
0.448 |
|
2009 |
Klifa C, Sand S, Vora L, Press M, Orisamolu A, Pike M, Spicer D, Daniels A, Blazer K, Weitzel J. Magnetic Resonance Imaging quantification of breast density in BRCA carriers following gonadotropin releasing hormone agonist (GnRHA)-based hormonal chemoprevention. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1506. PMID 27964319 DOI: 10.1200/Jco.2009.27.15_Suppl.1506 |
0.405 |
|
2009 |
Stone J, Folkerd E, Doody D, Schroen C, Treloar SA, Giles GG, Pike MC, English DR, Southey MC, Hopper JL, Dowsett M. Familial correlations in postmenopausal serum concentrations of sex steroid hormones and other mitogens: a twins and sisters study. The Journal of Clinical Endocrinology and Metabolism. 94: 4793-800. PMID 19850695 DOI: 10.1210/Jc.2009-0713 |
0.319 |
|
2009 |
Stern MC, Van Den Berg D, Yuan JM, Conti DV, Gago-Dominguez M, Pike MC, Xiang YB, Gao YT, Cortessis VK. Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3057-61. PMID 19843673 DOI: 10.1158/1055-9965.Epi-09-0492 |
0.45 |
|
2009 |
Johnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A, Webb PM, Goode EL, Rider DN, Vierkant RA, Anderson S, Wu AH, Pike M, Van Den Berg D, et al. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 12: 269-75. PMID 19456219 DOI: 10.1375/Twin.12.3.269 |
0.467 |
|
2009 |
Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE. Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. American Journal of Epidemiology. 169: 1251-9. PMID 19318616 DOI: 10.1093/Aje/Kwp036 |
0.41 |
|
2009 |
Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN, Pike MC, Hoover RN, Ziegler RG. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1050-9. PMID 19318430 DOI: 10.1158/1055-9965.Epi-08-0405 |
0.493 |
|
2009 |
Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, et al. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 100: 993-1001. PMID 19240718 DOI: 10.1038/Sj.Bjc.6604947 |
0.433 |
|
2009 |
Wu AH, Yu MC, Tseng C, Stanczyk FZ, Pike MC. Dietary patterns and breast cancer risk in Asian American women The American Journal of Clinical Nutrition. 89: 1145-1154. PMID 19211822 DOI: 10.3945/Ajcn.2008.26915 |
0.466 |
|
2009 |
Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH, Hawes D. Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast. Breast Cancer Research and Treatment. 118: 161-8. PMID 19205874 DOI: 10.1007/S10549-009-0322-4 |
0.358 |
|
2009 |
Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata D, Conti DV, Yuan JM, Pike MC, Gago-Dominguez M. Urinary tract infections and reduced risk of bladder cancer in Los Angeles British Journal of Cancer. 100: 834-839. PMID 19174821 DOI: 10.1038/Sj.Bjc.6604889 |
0.456 |
|
2009 |
Pearce CL, Chung K, Pike MC, Wu AH. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer. 115: 531-9. PMID 19127543 DOI: 10.1002/Cncr.23956 |
0.449 |
|
2009 |
Wu AH, Pearce CL, Tseng CC, Templeman C, Pike MC. Markers of inflammation and risk of ovarian cancer in Los Angeles County. International Journal of Cancer. Journal International Du Cancer. 124: 1409-15. PMID 19065661 DOI: 10.1002/Ijc.24091 |
0.5 |
|
2009 |
Woolcott CG, Maskarinec G, Pike MC, Henderson BE, Wilkens LR, Kolonel LN. Breast cancer risk and hysterectomy status: The Multiethnic Cohort study Cancer Causes and Control. 20: 539-547. PMID 19009364 DOI: 10.1007/S10552-008-9262-2 |
0.527 |
|
2009 |
Edwards QT, Li AX, Pike MC, Kolonel LN, Ursin G, Henderson BE, McKean-Cowdin R. Ethnic differences in the use of regular mammography: the multiethnic cohort. Breast Cancer Research and Treatment. 115: 163-70. PMID 18493849 DOI: 10.1007/S10549-008-0049-7 |
0.348 |
|
2009 |
O'Connell CL, Razavi P, McKean-Cowdin R, Pike MC. Impact of Ethnicity On Incidence and Survival Among Adults with Acute Lymphoblastic Leukemia in the United States; Insights From 2005 SEER Data. Blood. 114: 3069-3069. DOI: 10.1182/Blood.V114.22.3069.3069 |
0.308 |
|
2009 |
Chung K, Hovanessian-Larsen L, Hawes D, Taylor D, Paulson R, Pike M. Controlled ovarian hyperstimulation increases cell proliferation in normal breast tissue: implications for the magnitude of possible breast cancer risk from infertility treatment Fertility and Sterility. 92. DOI: 10.1016/J.Fertnstert.2009.07.1371 |
0.454 |
|
2008 |
Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, ... ... Pike MC, et al. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3567-72. PMID 19064572 DOI: 10.1158/1055-9965.Epi-08-0548 |
0.458 |
|
2008 |
Nomura AMY, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Pike MC, Kolonel LN. Association of vegetable, fruit, and grain intakes with colorectal cancer: The Multiethnic Cohort Study American Journal of Clinical Nutrition. 88: 730-737. PMID 18779290 DOI: 10.1093/Ajcn/88.3.730 |
0.466 |
|
2008 |
Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, Berg CD, Buring J, Calle EE, Chanock S, Clavel-Chapelon F, Cox DG, Dorronsoro M, Dossus L, Haiman CA, Hankinson SE, ... ... Pike MC, et al. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). Plos One. 3: e2578. PMID 18596909 DOI: 10.1371/Journal.Pone.0002578 |
0.625 |
|
2008 |
Pearce CL, Van Den Berg DJ, Makridakis N, Reichardt JK, Ross RK, Pike MC, Kolonel LN, Henderson BE. No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned. Human Molecular Genetics. 17: 2456-61. PMID 18469342 DOI: 10.1093/Hmg/Ddn145 |
0.433 |
|
2008 |
Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 123: 380-8. PMID 18431743 DOI: 10.1002/Ijc.23448 |
0.454 |
|
2008 |
Henderson KD, Bernstein L, Henderson B, Kolonel L, Pike MC. Predictors of the timing of natural menopause in the multiethnic cohort study American Journal of Epidemiology. 167: 1287-1294. PMID 18359953 DOI: 10.1093/Aje/Kwn046 |
0.684 |
|
2008 |
Stuedal A, Ma H, Bernstein L, Pike MC, Ursin G. Does breast size modify the association between mammographic density and breast cancer risk? Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 621-7. PMID 18349279 DOI: 10.1158/1055-9965.Epi-07-2554 |
0.562 |
|
2008 |
Leigh Pearce C, Near AM, Butler JL, Van Den Berg D, Bretsky P, Conti DV, Stram DO, Pike MC, Hirschhorn JN, Wu AH. Comprehensive evaluation of ESR2 variation and ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 393-6. PMID 18268123 DOI: 10.1158/1055-9965.Epi-07-2512 |
0.536 |
|
2008 |
Cox DG, Bretsky P, Kraft P, Pharoah P, Albanes D, Altshuler D, Amiano P, Berglund G, Boeing H, Buring J, Burtt N, Calle EE, Canzian F, Chanock S, ... ... Pike MC, et al. Haplotypes of the estrogen receptor beta gene and breast cancer risk. International Journal of Cancer. Journal International Du Cancer. 122: 387-92. PMID 17935138 DOI: 10.1002/Ijc.23127 |
0.534 |
|
2008 |
Setiawan VW, Monroe KR, Goodman MT, Kolonel LN, Pike MC, Henderson BE. Alcohol consumption and endometrial cancer risk: the multiethnic cohort. International Journal of Cancer. Journal International Du Cancer. 122: 634-8. PMID 17764072 DOI: 10.1002/Ijc.23072 |
0.446 |
|
2008 |
Fuhrman B, Xu X, Pfeiffer R, Wu A, Falk R, Korde L, Nomura A, West D, Kolonel L, Pike M, Keefer L, Veenstra T, Hoover R, Gail M, Ziegler R. Abstract B126: Does adult soy intake influence total estrogen levels and estrogen metabolism patterns? Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B126 |
0.46 |
|
2007 |
Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. Bmc Medical Genetics. 8: 72. PMID 18053149 DOI: 10.1186/1471-2350-8-72 |
0.49 |
|
2007 |
Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, Berglund G, Buring J, Calle EE, Clavel-Chapelon F, Cox DG, Gaziano JM, Hankinson SE, Hayes RB, Henderson BE, ... ... Pike MC, et al. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2237-46. PMID 18006912 DOI: 10.1158/1055-9965.Epi-07-0589 |
0.472 |
|
2007 |
Chen YC, Kraft P, Bretsky P, Ketkar S, Hunter DJ, Albanes D, Altshuler D, Andriole G, Berg CD, Boeing H, Burtt N, Bueno-de-Mesquita B, Cann H, Canzian F, Chanock S, ... ... Pike M, et al. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1973-81. PMID 17932344 DOI: 10.1158/1055-9965.Epi-07-0431 |
0.382 |
|
2007 |
Gill JK, Maskarinec G, Wilkens LR, Pike MC, Henderson BE, Kolonel LN. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. American Journal of Epidemiology. 166: 1150-8. PMID 17698973 DOI: 10.1093/Aje/Kwm195 |
0.494 |
|
2007 |
Nomura AM, Hankin JH, Henderson BE, Wilkens LR, Murphy SP, Pike MC, Le Marchand L, Stram DO, Monroe KR, Kolonel LN. Dietary fiber and colorectal cancer risk: the multiethnic cohort study. Cancer Causes & Control : Ccc. 18: 753-64. PMID 17557210 DOI: 10.1007/S10552-007-9018-4 |
0.375 |
|
2007 |
Wu AH, Pike MC, Williams LD, Spicer D, Tseng CC, Churchwell MI, Doerge DR. Tamoxifen, soy, and lifestyle factors in Asian American women with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3024-30. PMID 17536081 DOI: 10.1200/Jco.2006.10.5023 |
0.45 |
|
2007 |
Henderson SO, Haiman CA, Wilkens LR, Kolonel LN, Wan P, Pike MC. Established risk factors account for most of the racial differences in cardiovascular disease mortality Plos One. 2. PMID 17440613 DOI: 10.1371/Journal.Pone.0000377 |
0.379 |
|
2007 |
Wu AH, Yu MC, Tseng C, Stanczyk FZ, Pike MC. Diabetes and risk of breast cancer in Asian-American women Carcinogenesis. 28: 1561-1566. PMID 17440036 DOI: 10.1093/Carcin/Bgm081 |
0.496 |
|
2007 |
Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Pike MC, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261 |
0.413 |
|
2007 |
Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, Buring J, Calle EE, Chanock SJ, Colditz GA, Diver WR, Dunning AM, Freedman ML, Gaziano JM, Giovannucci E, Hankinson SE, ... ... Pike MC, et al. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Research. 67: 2951-6. PMID 17409400 DOI: 10.1158/0008-5472.Can-06-3591 |
0.49 |
|
2007 |
Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nature Genetics. 39: 638-44. PMID 17401364 DOI: 10.1038/Ng2015 |
0.418 |
|
2007 |
Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G, Thun MJ, Albanes D, Altshuler D, Ardanaz E, Boeing H, Buring J, Burtt N, Calle EE, Chanock S, ... ... Pike MC, et al. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Research. 67: 1893-7. PMID 17325027 DOI: 10.1158/0008-5472.Can-06-4123 |
0.5 |
|
2007 |
Weitzel JN, Buys SS, Sherman WH, Daniels A, Ursin G, Daniels JR, MacDonald DJ, Blazer KR, Pike MC, Spicer DV. Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 654-8. PMID 17255289 DOI: 10.1158/1078-0432.Ccr-06-1902 |
0.367 |
|
2007 |
Wu AH, Yu MC, Tseng C, Pike MC. Body size, hormone therapy and risk of breast cancer in Asian–American women International Journal of Cancer. 120: 844-852. PMID 17131315 DOI: 10.1002/Ijc.22387 |
0.498 |
|
2007 |
Setiawan VW, Pike MC, Kolonel LN, Nomura AM, Goodman MT, Henderson BE. Racial/ethnic differences in endometrial cancer risk: The multiethnic cohort study American Journal of Epidemiology. 165: 262-270. PMID 17090617 DOI: 10.1093/Aje/Kwk010 |
0.483 |
|
2006 |
Setiawan VW, Cheng I, Stram DO, Giorgi E, Pike MC, Van Den Berg D, Pooler L, Burtt NP, Le Marchand L, Altshuler D, Hirschhorn J, Henderson BE, Haiman CA. A systematic assessment of common genetic variation in CYP11A and risk of breast cancer. Cancer Research. 66: 12019-25. PMID 17178901 DOI: 10.1158/0008-5472.Can-06-1101 |
0.485 |
|
2006 |
Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE, Freedman ML. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1993-7. PMID 17035411 DOI: 10.1158/1055-9965.Epi-06-0361 |
0.453 |
|
2006 |
Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, ... ... Pike MC, et al. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1863-70. PMID 17021353 DOI: 10.1158/1055-9965.Epi-06-0258 |
0.428 |
|
2006 |
Stram DO, Hankin JH, Wilkens LR, Park S, Henderson BE, Nomura AM, Pike MC, Kolonel LN. Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States). Cancer Causes & Control : Ccc. 17: 1193-207. PMID 17006725 DOI: 10.1007/S10552-006-0064-0 |
0.37 |
|
2006 |
Cox DG, Blanché H, Pearce CL, Calle EE, Colditz GA, Pike MC, Albanes D, Allen NE, Amiano P, Berglund G, Boeing H, Buring J, Burtt N, Canzian F, Chanock S, et al. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Research : Bcr. 8: R54. PMID 16987421 DOI: 10.1186/Bcr1602 |
0.479 |
|
2006 |
Ursin G, Pike M. Mammographic density, hormone therapy, and risk of breast cancer [1] Cancer Epidemiology Biomarkers and Prevention. 15: 1750. PMID 16985042 DOI: 10.1158/1055-9965.Epi-06-0431 |
0.431 |
|
2006 |
Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Research : Bcr. 8: R43. PMID 16859501 DOI: 10.1186/Bcr1525 |
0.598 |
|
2006 |
Hawes D, Downey S, Pearce CL, Bartow S, Wan P, Pike MC, Wu AH. Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Research : Bcr. 8: R24. PMID 16646977 DOI: 10.1186/Bcr1408 |
0.41 |
|
2006 |
Feigelson HS, Cox DG, Cann HM, Wacholder S, Kaaks R, Henderson BE, Albanes D, Altshuler D, Berglund G, Berrino F, Bingham S, Buring JE, Burtt NP, Calle EE, Chanock SJ, ... ... Pike MC, et al. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Research. 66: 2468-75. PMID 16489054 DOI: 10.1158/0008-5472.Can-05-3574 |
0.506 |
|
2006 |
Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, Marchand LL. Ethnic and racial differences in the smoking-related risk of lung cancer New England Journal of Medicine. 354: 333-342. PMID 16436765 DOI: 10.1056/Nejmoa033250 |
0.383 |
|
2006 |
Cheng I, Stram DO, Penney KL, Pike M, Le Marchand L, Kolonel LN, Hirschhorn J, Altshuler D, Henderson BE, Freedman ML. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. Journal of the National Cancer Institute. 98: 123-34. PMID 16418515 DOI: 10.1093/Jnci/Djj013 |
0.348 |
|
2006 |
Lee S, Kolonel L, Wilkens L, Wan P, Henderson B, Pike M. Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort. International Journal of Cancer. 118: 1285-91. PMID 16170777 DOI: 10.1002/Ijc.21481 |
0.492 |
|
2006 |
Pike MC. The role of mammographic density in evaluating changes in breast cancer risk. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 1-5. PMID 16112948 DOI: 10.1080/09513590400030038 |
0.412 |
|
2005 |
Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, ... ... Pike M, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. American Journal of Human Genetics. 77: 1034-43. PMID 16380914 DOI: 10.1086/498455 |
0.378 |
|
2005 |
Gago-Dominguez M, Castelao JE, Pike MC, Sevanian A, Haile RW. Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2829-39. PMID 16364997 DOI: 10.1158/1055-9965.Epi-05-0015 |
0.448 |
|
2005 |
Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB, Altshuler D, Andriole G, Berg C, Boeing H, Burtt NP, Bueno-de-Mesquita B, Calle EE, Cann H, Canzian F, ... ... Pike MC, et al. Genetic variation in the HSD17B1 gene and risk of prostate cancer. Plos Genetics. 1: e68. PMID 16311626 DOI: 10.1371/Journal.Pgen.0010068 |
0.413 |
|
2005 |
Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: Results from the postmenopausal estrogen/progestin interventions mammographic density study American Journal of Epidemiology. 162: 826-834. PMID 16177147 DOI: 10.1093/Aje/Kwi286 |
0.432 |
|
2005 |
Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue Breast Cancer Research : Bcr. 7. PMID 16168104 DOI: 10.1186/Bcr1260 |
0.394 |
|
2005 |
Cheng I, Yu MC, Koh WP, Pike MC, Kolonel LN, Henderson BE, Stram DO. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1692-6. PMID 16030103 DOI: 10.1158/1055-9965.Epi-04-0864 |
0.349 |
|
2005 |
Lord SJ, Mack WJ, Van Den Berg D, Pike MC, Ingles SA, Haiman CA, Wang W, Parisky YR, Hodis HN, Ursin G. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study. Breast Cancer Research : Bcr. 7: R336-44. PMID 15987428 DOI: 10.1186/Bcr999 |
0.434 |
|
2005 |
Wu AH, Stanczyk FZ, Martinez C, Tseng CC, Hendrich S, Murphy P, Chaikittisilpa S, Stram DO, Pike MC. A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. The American Journal of Clinical Nutrition. 81: 1133-41. PMID 15883439 DOI: 10.1093/Ajcn/81.5.1133 |
0.347 |
|
2005 |
Chodankar R, Kwang S, Sangiorgi F, Hong H, Yen HY, Deng C, Pike MC, Shuler CF, Maxson R, Dubeau L. Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Current Biology : Cb. 15: 561-5. PMID 15797026 DOI: 10.1016/J.Cub.2005.01.052 |
0.403 |
|
2005 |
Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. Journal of the National Cancer Institute. 97: 51-9. PMID 15632380 DOI: 10.1093/Jnci/Dji007 |
0.517 |
|
2004 |
Pike MC, Pearce CL, Wu AH. Prevention of cancers of the breast, endometrium and ovary Oncogene. 23: 6379-6391. PMID 15322512 DOI: 10.1038/Sj.Onc.1207899 |
0.503 |
|
2004 |
Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH. Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertility and Sterility. 82: 186-95. PMID 15237010 DOI: 10.1016/J.Fertnstert.2004.03.013 |
0.488 |
|
2004 |
Coupland CAC, Forman D, Chilvers CED, Davey G, Pike MC, Oliver RTD. Maternal risk factors for testicular cancer: a population-based case-control study (UK). Cancer Causes & Control. 15: 277-283. PMID 15090722 DOI: 10.1023/B:Caco.0000024257.49409.1F |
0.476 |
|
2004 |
Cozen W, Gill PS, Ingles SA, Masood R, Martínez-Maza O, Cockburn MG, Gauderman WJ, Pike MC, Bernstein L, Nathwani BN, Salam MT, Danley KL, Wang W, Gage J, Gundell-Miller S, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 103: 3216-21. PMID 15070705 DOI: 10.1182/Blood-2003-08-2860 |
0.429 |
|
2004 |
Chen Z, Wu AH, Gauderman WJ, Bernstein L, Ma H, Pike MC, Ursin G. Does mammographic density reflect ethnic differences in breast cancer incidence rates? American Journal of Epidemiology. 159: 140-7. PMID 14718215 DOI: 10.1093/Aje/Kwh028 |
0.555 |
|
2004 |
Ursin G, Palla SL, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Greendale GA. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the postmenopausal estrogen/progestin interventions (PEPI) trial Journal of Clinical Oncology. 22: 2845-2848. DOI: 10.1200/Jco.2004.03.120 |
0.337 |
|
2004 |
Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH. Erratum: Hormonal factors and the risk of invasive ovarian cancer: A population-based case-control study (Fertility and Sterility (2004) 82:1 (186-195)) Fertility and Sterility. 82. DOI: 10.1016/J.Fertnstert.2004.07.923 |
0.443 |
|
2003 |
Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Human Molecular Genetics. 12: 2679-92. PMID 12944421 DOI: 10.1093/Hmg/Ddg294 |
0.492 |
|
2003 |
Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, Pike MC. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Human Heredity. 55: 27-36. PMID 12890923 DOI: 10.1159/000071807 |
0.353 |
|
2003 |
Monroe KR, Hankin JH, Pike MC, Henderson BE, Stram DO, Park S, Nomura AM, Wilkens LR, Kolonel LN. Correlation of dietary intake and colorectal cancer incidence among Mexican-American migrants: the multiethnic cohort study. Nutrition and Cancer. 45: 133-47. PMID 12881006 DOI: 10.1207/S15327914Nc4502_01 |
0.412 |
|
2003 |
Wu AH, Yu MC, Tseng CC, Hankin J, Pike MC. Green tea and risk of breast cancer in Asian Americans International Journal of Cancer. 106: 574-579. PMID 12845655 DOI: 10.1002/Ijc.11259 |
0.529 |
|
2003 |
Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 332-8. PMID 12692108 |
0.548 |
|
2003 |
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genetics. 33: 177-82. PMID 12524541 DOI: 10.1038/Ng1071 |
0.314 |
|
2003 |
Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density Journal of the National Cancer Institute. 95: 30-37. PMID 12509398 DOI: 10.1093/Jnci/95.1.30 |
0.371 |
|
2002 |
Pike MC, Ross RK. Estrogen-progestin replacement therapy: regulatory action needed. Breast Cancer Research : Bcr. 4: 222-3. PMID 12473167 DOI: 10.1186/Bcr550 |
0.488 |
|
2002 |
Pike MC, Kolonel LN, Henderson BE, Wilkens LR, Hankin JH, Feigelson HS, Wan PC, Stram DO, Nomura AMY. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: Risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites Cancer Epidemiology Biomarkers and Prevention. 11: 795-800. PMID 12223421 |
0.399 |
|
2002 |
Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis. 23: 1491-6. PMID 12189192 DOI: 10.1093/Carcin/23.9.1491 |
0.486 |
|
2002 |
Ursin G, London S, Yang D, Tseng CC, Pike MC, Bernstein L, Stanczyk FZ, Gentzschein E. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. Breast Cancer Research and Treatment. 72: 139-43. PMID 12038704 DOI: 10.1023/A:1014896417653 |
0.563 |
|
2002 |
Cozen W, Peters R, Reichardt JK, Ng W, Felix JC, Wan P, Pike MC. Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes & Control : Ccc. 13: 113-20. PMID 11936817 DOI: 10.1023/A:1014384027523 |
0.518 |
|
2002 |
Ursin G, Tseng CC, Paganini-Hill A, Enger S, Wan PC, Formenti S, Pike MC, Ross RK. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 699-706. PMID 11821451 DOI: 10.1200/Jco.20.3.699 |
0.519 |
|
2000 |
Spicer DV, Pike MC. Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists Breast Cancer Research. 2: 264-267. PMID 11250719 DOI: 10.1186/Bcr67 |
0.445 |
|
2000 |
Pike MC, Ross RK. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids. 65: 659-664. PMID 11108873 DOI: 10.1016/S0039-128X(00)00122-7 |
0.503 |
|
2000 |
Lu JJ, Zheng Y, Kang X, Yuan JM, Lauchlan SC, Pike MC, Zheng W. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer. Gynecologic Oncology. 79: 158-168. PMID 11063638 DOI: 10.1006/Gyno.2000.5928 |
0.315 |
|
2000 |
Ursin G, Li C, Pike MC. Should women with a family history of breast cancer avoid use of oral contraceptives? [4] Epidemiology. 11: 615-616. PMID 10955421 DOI: 10.1097/00001648-200009000-00026 |
0.434 |
|
2000 |
Ross RK, Pike MC. Response: Re: Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin Journal of the National Cancer Institute. 92: 1951-1952. PMID 10880557 DOI: 10.1093/Jnci/92.13.1100A |
0.444 |
|
2000 |
McKean-Cowdin R, Feigelson HS, Ross RK, Pike MC, Henderson BE. Declining cancer rates in the 1990s Journal of Clinical Oncology. 18: 2258-2268. PMID 10829046 DOI: 10.1200/Jco.2000.18.11.2258 |
0.411 |
|
2000 |
Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME, Nagamine FS. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. American Journal of Epidemiology. 151: 346-57. PMID 10695593 DOI: 10.1093/Oxfordjournals.Aje.A010213 |
0.39 |
|
2000 |
Zheng W, Luo F, Lu JJ, Baltayan A, Press MF, Zhang ZF, Pike MC. Reduction of BRCA1 expression in sporadic ovarian cancer. Gynecologic Oncology. 76: 294-300. PMID 10684699 DOI: 10.1006/Gyno.1999.5664 |
0.367 |
|
2000 |
Zheng W, Lu JJ, Luo F, Zheng Y, Feng Yj, Felix JC, Lauchlan SC, Pike MC. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecologic Oncology. 76: 80-8. PMID 10620446 DOI: 10.1006/Gyno.1999.5628 |
0.358 |
|
1999 |
Makridakis NM, Ross RK, Pike MC, Crocitto LE, Kolonel LN, Pearce CL, Henderson BE, Reichardt JK. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet (London, England). 354: 975-8. PMID 10501358 DOI: 10.1016/S0140-6736(98)11282-5 |
0.377 |
|
1999 |
Ursin G, Wu AH, Hoover RN, West DW, Nomura AMY, Kolonel LN, Pike MC, Ziegler RG. Breast cancer and oral contraceptive use in Asian-American women American Journal of Epidemiology. 150: 561-567. PMID 10489994 DOI: 10.1093/Oxfordjournals.Aje.A010053 |
0.478 |
|
1999 |
Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute. 91: 1067-72. PMID 10379970 DOI: 10.1093/Jnci/91.12.1067 |
0.458 |
|
1999 |
Wu AH, Pike MC, Stram DO. Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer Journal of the National Cancer Institute. 91: 529-534. PMID 10088623 DOI: 10.1093/Jnci/91.6.529 |
0.468 |
|
1998 |
Wu AH, Ziegler RG, Nomura AMY, West DW, Kolonel LN, Horn-Ross PL, Hoover RN, Pike MC. Soy intake and risk of breast cancer in Asians and Asian Americans. The American Journal of Clinical Nutrition. 68: 1437-1443. PMID 9848513 DOI: 10.1093/Ajcn/68.6.1437S |
0.499 |
|
1998 |
Cote RJ, Skinner EC, Salem CE, Mertes SJ, Stanczyk FZ, Henderson BE, Pike MC, Ross RK. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels British Journal of Cancer. 78: 413-418. PMID 9703292 DOI: 10.1038/Bjc.1998.508 |
0.327 |
|
1998 |
Pike MC, Ross RK, Spicer DV. Problems Involved in Including Women with Simple Hysterectomy in Epidemiologic Studies Measuring the Effects of Hormone Replacement Therapy on Breast Cancer Risk American Journal of Epidemiology. 147: 718-721. PMID 9554412 DOI: 10.1093/Oxfordjournals.Aje.A009515 |
0.475 |
|
1998 |
Bradlow HL, Kabat GC, Ursin G, London S, Pike MC. Re: 'A pilot study of urinary estrogen metabolites (16α-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer' (multiple letters) [3] Environmental Health Perspectives. 106. DOI: 10.2307/3434300 |
0.443 |
|
1997 |
Henderson BE, Feigelson HS, Pike MC. Re: Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality Rates Journal of the National Cancer Institute. 89: 1810-1810. PMID 9392623 DOI: 10.1093/Jnci/89.23.1810 |
0.385 |
|
1997 |
Devgan SA, Henderson BE, Yu MC, Shi CY, Pike MC, Ross RK, Reichardt JK. Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk. The Prostate. 33: 9-12. PMID 9294620 DOI: 10.1002/(Sici)1097-0045(19970915)33:1<9::Aid-Pros2>3.0.Co;2-H |
0.371 |
|
1997 |
Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Environmental Health Perspectives. 105: 601-5. PMID 9168002 DOI: 10.1289/Ehp.97105S3601 |
0.44 |
|
1997 |
Pike MC, Daniels JR, Spicer DV. A hormonal contraceptive approach to reducing breast and ovarian cancer risk: an update Endocrine-Related Cancer. 4: 125-133. DOI: 10.1677/Erc.0.0040125 |
0.496 |
|
1996 |
Key TJ, Pike MC, Brown JB, Hermon C, Allen DS, Wang DY. Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women. British Journal of Cancer. 74: 1313-6. PMID 8883424 DOI: 10.1038/Bjc.1996.536 |
0.359 |
|
1996 |
Ursin G, Pike MC, Preston-Martin S, D'Ablaing G, Peters RK. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: Results from a population-based case-control study (California, United States) Cancer Causes and Control. 7: 391-401. PMID 8734834 DOI: 10.1007/Bf00052946 |
0.44 |
|
1996 |
Key TJ, Wang DY, Brown JB, Hermon C, Allen DS, Moore JW, Bulbrook RD, Fentiman IS, Pike MC. A prospective study of urinary oestrogen excretion and breast cancer risk. British Journal of Cancer. 73: 1615-9. PMID 8664140 DOI: 10.1038/Bjc.1996.304 |
0.533 |
|
1996 |
Ziegler RG, Hoover RN, Nomura AM, West DW, Wu AH, Pike MC, Lake AJ, Horn-Ross PL, Kolonel LN, Siiteri PK, Fraumeni JF. Relative weight, weight change, height, and breast cancer risk in Asian-American women. Journal of the National Cancer Institute. 88: 650-60. PMID 8627641 DOI: 10.1093/Jnci/88.10.650 |
0.506 |
|
1996 |
Key TJ, Bull D, Ansell P, Brett AR, Clark GM, Moore JW, Chilvers CE, Pike MC. A case-control study of cryptorchidism and maternal hormone concentrations in early pregnancy. British Journal of Cancer. 73: 698-701. PMID 8605110 DOI: 10.1038/Bjc.1996.121 |
0.302 |
|
1996 |
Ursin G, Pike MC, Spicer DV, Porrath SA, Reitherman RW. Can mammographic densities predict effects of tamoxifen on the breast? Journal of the National Cancer Institute. 88: 128-129. PMID 8537975 DOI: 10.1093/Jnci/88.2.128-A |
0.315 |
|
1996 |
Ursin G, Pike MC, Spicer DV. A CASE-CONTROL STUDY OF COMBINED CONTINUOUS ESTROGEN-PROGESTIN REPLACEMENT THERAPY AMONG WOMEN WITH A PERSONAL HISTORY OF BREAST CANCER Menopause. 3: 118-119. DOI: 10.1097/00042192-199603020-00010 |
0.445 |
|
1995 |
Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC. Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. American Journal of Epidemiology. 142: 813-9. PMID 7572957 DOI: 10.1093/Oxfordjournals.Aje.A117720 |
0.458 |
|
1995 |
Spicer DV, Krecker EA, Pike MC. The endocrine prevention of breast cancer Cancer Investigation. 13: 495-504. PMID 7552817 DOI: 10.3109/07357909509024914 |
0.473 |
|
1994 |
Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, Tokunaga M. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes & Control : Ccc. 5: 167-76. PMID 8167264 DOI: 10.1007/Bf01830263 |
0.368 |
|
1994 |
Land CE, Hayakawa N, Machado SG, Yamada Y, Pike MC, Akiba S, Tokunaga M. A case-control interview study of breast cancer among Japanese A-bomb survivors. I. Main effects. Cancer Causes & Control : Ccc. 5: 157-65. PMID 8167263 DOI: 10.1007/Bf01830262 |
0.498 |
|
1994 |
Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk Journal of the National Cancer Institute. 86: 431-436. PMID 8120917 DOI: 10.1093/Jnci/86.6.431 |
0.479 |
|
1994 |
Eaton SB, Pike MC, Short RV, Lee NC, Trussell J, Hatcher RA, Wood JW, Worthman CM, Jones NG, Konner MJ. Women's reproductive cancers in evolutionary context. The Quarterly Review of Biology. 69: 353-67. PMID 7972680 DOI: 10.1086/418650 |
0.461 |
|
1994 |
Shames LS, Munekata MT, Pike MC. Re: Blood Levels of Organochlorine Residues and Risk of Breast Cancer Journal of the National Cancer Institute. 86: 1642-1643. PMID 7802816 DOI: 10.1093/Jnci/86.21.1642 |
0.455 |
|
1993 |
Pike MC, Peters RK, Bernstein L. Re: "Total energy intake: implications for epidemiologic analyses". American Journal of Epidemiology. 137: 811-3. PMID 8484372 DOI: 10.1093/Oxfordjournals.Aje.A116741 |
0.381 |
|
1993 |
Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk Epidemiologic Reviews. 15: 17-35. PMID 8405201 DOI: 10.1093/Oxfordjournals.Epirev.A036102 |
0.443 |
|
1993 |
Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB. Migration Patterns and Breast Cancer Risk in Asian-American Women Journal of the National Cancer Institute. 85: 1819-1827. PMID 8230262 DOI: 10.1093/Jnci/85.22.1819 |
0.52 |
|
1993 |
Spicer DV, Pike MC. Breast cancer prevention through modulation of endogenous hormones. Breast Cancer Research and Treatment. 28: 179-193. PMID 8173070 DOI: 10.1007/Bf00666430 |
0.496 |
|
1993 |
Pike MC, Spicer DV. The chemoprevention of breast cancer by reducing sex steroid exposure: Perspectives from epidemiology Journal of Cellular Biochemistry. 53: 26-36. PMID 8007706 DOI: 10.1002/Jcb.240531105 |
0.44 |
|
1993 |
Pike MC, Spicer DV. Oral contraceptives and cancer Minerva Ginecologica. 58: 67-84. DOI: 10.1007/978-1-4612-2730-4_7 |
0.52 |
|
1992 |
Spicer DV, Pike MC. The Prevention of Breast Cancer through Reduced Ovarian Steroid Exposure Acta Oncologica. 31: 167-174. PMID 1622631 DOI: 10.3109/02841869209088898 |
0.501 |
|
1992 |
Cassidenti DL, Pike MC, Vijod AG, Stanczyk FZ, Lobo RA. A reevaluation of estrogen status in postmenopausal women who smoke. American Journal of Obstetrics and Gynecology. 166: 1444-1448. PMID 1534446 DOI: 10.1016/0002-9378(92)91617-J |
0.385 |
|
1992 |
Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County, California Cancer Causes & Control. 3: 457-473. PMID 1525327 DOI: 10.1007/Bf00051359 |
0.399 |
|
1992 |
Pike MC, Bernstein L, Peters RK. Re: Dietary fat and postmenopausal breast cancer. Journal of the National Cancer Institute. 84: 1666-9. PMID 1433348 DOI: 10.1093/Jnci/84.21.1666 |
0.548 |
|
1991 |
Bernstein L, Yuan JM, Ross RK, Pike MC, Hanisch R, Lobo R, Stanczyk F, Gao YT, Henderson BE. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes & Control : Ccc. 1: 51-8. PMID 2102277 DOI: 10.1007/Bf00053183 |
0.58 |
|
1991 |
Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer Science. 254: 1131-1138. PMID 1957166 DOI: 10.1126/Science.1957166 |
0.445 |
|
1991 |
Bernstein L, Pike MC, Ross RK, Henderson BE. Age at menarche and estrogen concentrations of adult women. Cancer Causes & Control : Ccc. 2: 221-5. PMID 1873451 DOI: 10.1007/Bf00052137 |
0.445 |
|
1991 |
Spicer DV, Shoupe D, Pike MC. GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer. Contraception. 44: 289-310. PMID 1662596 DOI: 10.1016/0010-7824(91)90019-C |
0.44 |
|
1991 |
Pike MC. Estrogen Replacement Therapy and Risk of Breast Cancer Jama: the Journal of the American Medical Association. 265: 1824. DOI: 10.1001/Jama.1991.03460140052013 |
0.492 |
|
1990 |
Key TJA, Chen J, Wang DY, Pike MC, Boreham J. Sex hormones in women in rural China and in Britain. British Journal of Cancer. 62: 631-636. PMID 2223580 DOI: 10.1038/Bjc.1990.344 |
0.37 |
|
1990 |
Key TJ, Pike MC, Wang DY, Moore JW. Long term effects of a first pregnancy on serum concentrations of dehydroepiandrosterone sulfate and dehydroepiandrosterone. The Journal of Clinical Endocrinology and Metabolism. 70: 1651-3. PMID 2140833 DOI: 10.1210/Jcem-70-6-1651 |
0.31 |
|
1989 |
Bernstein L, Pike MC, Lobo RA, Depue RH, Ross RK, Henderson BE. Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels. British Journal of Obstetrics and Gynaecology. 96: 92-6. PMID 2923845 DOI: 10.1111/J.1471-0528.1989.Tb01582.X |
0.422 |
|
1988 |
Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer European Journal of Cancer and Clinical Oncology. 24: 29-43. PMID 3276531 DOI: 10.1016/0277-5379(88)90173-3 |
0.489 |
|
1988 |
Moore JW, Key TJ, Clark GM, Bulbrook RD, Allen DS, Wang DY, Pike MC. Concentrations of sex-hormone-binding-globulin (SHBG) in a population of normal women: relationship to risk factors for breast cancer. Steroids. 52: 391-2. PMID 3250032 DOI: 10.1016/0039-128X(88)90162-6 |
0.474 |
|
1988 |
Darby SC, Pike MC. Lung cancer and passive smoking: predicted effects from a mathematical model for cigarette smoking and lung cancer. British Journal of Cancer. 58: 825-831. PMID 3224084 DOI: 10.1038/Bjc.1988.319 |
0.338 |
|
1988 |
Westhoff C, Pike M, Vessey M. Benign ovarian teratomas: a population-based case-control study. British Journal of Cancer. 58: 93-8. PMID 3166898 DOI: 10.1038/Bjc.1988.171 |
0.385 |
|
1987 |
Krailo M, Thomas DC, Pike MC. Fitting models of carcinogenesis to a case-control study of breast cancer. Journal of Chronic Diseases. 181S-189S. PMID 3667865 DOI: 10.1016/S0021-9681(87)80021-8 |
0.364 |
|
1987 |
Forman D, Cook-Mozaffari P, Darby S, Davey G, Stratton I, Doll R, Pike M. Cancer near nuclear installations Nature. 329: 499-505. PMID 3657974 DOI: 10.1038/329499A0 |
0.386 |
|
1987 |
Moore JW, Key TJ, Bulbrook RD, Clark GM, Allen DS, Wang DY, Pike MC. Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. British Journal of Cancer. 56: 661-6. PMID 3426933 DOI: 10.1038/Bjc.1987.262 |
0.435 |
|
1987 |
Key TJA, Darby SC, Pike MC. Trends in breast cancer mortality and diet in England and Wales from 1911 to 1980. Nutrition and Cancer. 10: 1-9. PMID 3302960 DOI: 10.1080/01635588709513935 |
0.389 |
|
1986 |
Deapen DM, Pike MC, Casagrande JT, Brody GS. The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plastic and Reconstructive Surgery. 77: 361-367. PMID 3952193 DOI: 10.1097/00006534-198603000-00001 |
0.505 |
|
1986 |
Ottman R, Pike MC, King MC, Casagrande JT, Henderson BE. Familial breast cancer in a population-based series. American Journal of Epidemiology. 123: 15-21. PMID 3940434 DOI: 10.1093/Oxfordjournals.Aje.A114209 |
0.44 |
|
1986 |
Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Bmj. 293: 359-362. PMID 3730804 DOI: 10.1136/Bmj.293.6543.359 |
0.426 |
|
1986 |
Depue RH, Pike MC, Henderson BE. Birth Weight and the Risk of Testicular Cancer: Reply Journal of the National Cancer Institute. 77: 829-830. DOI: 10.1093/Jnci/77.3.829-A |
0.413 |
|
1986 |
Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE. Higher Maternal Levels of Free Estradiol in First Compared to Second Pregnancy: Early Gestational Differences Journal of the National Cancer Institute. 76: 1035-1039. DOI: 10.1093/Jnci/76.6.1035 |
0.45 |
|
1986 |
Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B. Serum Testosterone Levels in Healthy Young Black and White Men Journal of the National Cancer Institute. 76: 45-48. DOI: 10.1093/Jnci/76.1.45 |
0.486 |
|
1985 |
Bernstein L, Gold LS, Ames BN, Pike MC, Hoel DG. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 5: 79-86. PMID 3987994 DOI: 10.1016/0272-0590(85)90051-X |
0.398 |
|
1985 |
Pike MC, Bernstein L. Statistical errors invalidate conclusions in "Caffeine and unsaturated fat diet significantly promotes DMBA-induced breast cancer in rats". Cancer. 55: 1855-8. PMID 3919918 DOI: 10.1002/1097-0142(19850415)55:8<1855::Aid-Cncr2820550835>3.0.Co;2-9 |
0.503 |
|
1985 |
Wu AH, Henderson BE, Pike MC, Yu MC. Smoking and other risk factors for lung cancer in women. Journal of the National Cancer Institute. 74: 747-751. DOI: 10.1093/Jnci/74.4.747 |
0.393 |
|
1985 |
Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE. Estrogen and Sex Hormone-Binding Globulin Levels in Nulliparous and Parous Women Journal of the National Cancer Institute. 74: 741-745. DOI: 10.1093/Jnci/74.4.741 |
0.531 |
|
1984 |
Paganini-Hill A, Krailo MD, Pike MC. Age At Natural Menopause And Breast Cancer Risk: The Effect Of Errors In Recall American Journal of Epidemiology. 119: 81-85. PMID 6691338 DOI: 10.1093/Oxfordjournals.Aje.A113728 |
0.458 |
|
1984 |
Sawyer C, Peto R, Bernstein L, Pike MC. Calculation of Carcinogenic Potency from Long-Term Animal Carcinogenesis Experiments Biometrics. 40: 27. DOI: 10.2307/2530741 |
0.391 |
|
1984 |
Peto R, Pike MC, Bernstein L, Gold LS, Ames BN. The TD 50 : A Proposed General Convention for the Numerical Description of the Carcinogenic Potency of Chemicals in Chronic-Exposure Animal Experiments Environmental Health Perspectives. 58: 1. DOI: 10.1289/Ehp.84581 |
0.396 |
|
1984 |
Depue RH, Pike MC, Henderson BE. Estrogen Exposure During Gestation and Risk of Testicular Cancer The Journal of Urology. 132: 1063-1063. DOI: 10.1016/S0022-5347(17)50014-2 |
0.445 |
|
1983 |
Hoel DG, Wakabayashi T, Pike MC. Secular trends in the distributions of the breast cancer risk factors-menarche, first birth, menopause, and weight-in Hiroshima and Nagasaki, Japan American Journal of Epidemiology. 118: 78-89. PMID 6869366 DOI: 10.1093/Oxfordjournals.Aje.A113619 |
0.455 |
|
1983 |
Peters RK, Cady LD, Bischoff DP, Bernstein L, Pike MC. Physical fitness and subsequent myocardial infarction in healthy workers. Jama. 249: 3052-6. PMID 6854827 DOI: 10.1001/Jama.1983.03330460034028 |
0.472 |
|
1983 |
Depue RH, Pike MC, Henderson BE. Estrogen Exposure During Gestation and Risk of Testicular Cancer Journal of the National Cancer Institute. 71: 1151-1155. DOI: 10.1093/Jnci/71.6.1151 |
0.479 |
|
1982 |
Gray GE, Pike MC, Hirayama T, Tellez J, Gerkins V, Brown JB, Casagrande JT, Henderson BE. Diet and hormone profiles in teenage girls in four countries at different risk for breast cancer. Preventive Medicine. 11: 108-113. PMID 7079243 DOI: 10.1016/0091-7435(82)90010-X |
0.337 |
|
1982 |
Gray GE, Williams P, Gerkins V, Brown JB, Armstrong B, Phillips R, Casagrande JT, Pike MC, Henderson BE. Diet and hormone levels in seventh-day adventist teenage girls Preventive Medicine. 11: 103-107. PMID 7079242 DOI: 10.1016/0091-7435(82)90009-3 |
0.398 |
|
1982 |
Preston-Martin S, Henderson BE, Pike MC. Descriptive epidemiology of cancers of the upper respiratory tract in Los Angeles. Cancer. 49: 2201-2207. PMID 7074536 DOI: 10.1002/1097-0142(19820515)49:10<2201::Aid-Cncr2820491037>3.0.Co;2-U |
0.457 |
|
1980 |
Preston-Martin S, Paganini-Hill A, Henderson BE, Pike MC, Wood C. Case-Control Study of Intracranial Menigiomas in Women in Los Angeles County, California Journal of the National Cancer Institute. 65: 67-73. DOI: 10.1093/Jnci/65.1.67 |
0.31 |
|
1980 |
Gray GE, Henderson BE, Pike MC. Changing Ratio of Breast Cancer Incidence Rates With Age of Black Females Compared With White Females in the United States Journal of the National Cancer Institute. 64: 461-463. DOI: 10.1093/Jnci/64.3.461 |
0.453 |
|
1979 |
Gray GE, Pike MC, Henderson BE. Breast-cancer incidence and mortality rates in different countries in relation to known risk factors and dietary practices. British Journal of Cancer. 39: 1-7. PMID 758926 DOI: 10.1038/Bjc.1979.1 |
0.478 |
|
1977 |
Breslow L, Henderson B, Massey F, Pike M, Winkelstein W. Report of NCI AD Hoc Working Group on the Gross and Net Benefits of Mammography in Mass Screening for the Detection of Breast Cancer Journal of the National Cancer Institute. 59: 474-478. DOI: 10.1093/Jnci/59.2.474 |
0.359 |
|
1976 |
Mack TM, Pike MC, Henderson BE, Pfeffer RI, Gerkins VR, Arthur M, Brown SE. Estrogens and Endometrial Cancer in a Retirement Community The New England Journal of Medicine. 294: 1262-1267. PMID 177870 DOI: 10.1056/Nejm197606032942304 |
0.471 |
|
1975 |
Henderson BR, Gerkins V, Rosario I, Casagrande J, Pike MC. Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. The New England Journal of Medicine. 293: 790-5. PMID 1160970 DOI: 10.1056/Nejm197510162931602 |
0.421 |
|
1975 |
Henderson BE, Gordon RJ, Menck H, Soohoo J, Martin SP, Pike MC. Lung cancer and air pollution in southcentral Los Angeles County. American Journal of Epidemiology. 101: 477-88. PMID 1155427 DOI: 10.1093/Oxfordjournals.Aje.A112118 |
0.375 |
|
1975 |
Mack TM, Henderson BE, Gerkins VR, Arthur M, Baptista J, Pike MC. Reserpine and Breast Cancer in a Retirement Community The New England Journal of Medicine. 292: 1366-1371. PMID 1138164 DOI: 10.1056/Nejm197506262922603 |
0.404 |
|
1975 |
Pike MC, Henderson BE. Clustering of cancer. Ca: a Cancer Journal For Clinicians. 25: 230-234. PMID 805640 DOI: 10.3322/Canjclin.25.4.230 |
0.328 |
|
Show low-probability matches. |